Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: identification of lupus anticoagulants.

Malaeb BS, Gardner TA, Margulis V, Yang L, Gillenwater JY, Chung LW, Macik G, Koeneman KS.

Urology. 2005 Oct;66(4):830-4.

PMID:
16230147
2.

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer.

Kubo H, Gardner TA, Wada Y, Koeneman KS, Gotoh A, Yang L, Kao C, Lim SD, Amin MB, Yang H, Black ME, Matsubara S, Nakagawa M, Gillenwater JY, Zhau HE, Chung LW.

Hum Gene Ther. 2003 Feb 10;14(3):227-41.

PMID:
12639303
3.

Combined analysis of two multicenter studies of finasteride 5 mg in the treatment of symptomatic benign prostatic hyperplasia.

Byrnes CA, Liss CL, Tenover JL, Lippert MC, Gillenwater JY.

Prostate Cancer Prostatic Dis. 1997 Sep;1(1):26-31.

4.

This month in clinical urology.

Gillenwater JY.

J Urol. 2002 Nov;168(5):1887-8. No abstract available.

PMID:
12402844
5.

A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.

Matsubara S, Wada Y, Gardner TA, Egawa M, Park MS, Hsieh CL, Zhau HE, Kao C, Kamidono S, Gillenwater JY, Chung LW.

Cancer Res. 2001 Aug 15;61(16):6012-9.

6.

Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy.

Older RA, Synder B, Krupski TL, Glembocki DJ, Gillenwater JY.

J Urol. 2001 May;165(5):1590-2.

PMID:
11342923
7.

Prostatourethral-rectal fistula after prostate brachytherapy.

Theodorescu D, Gillenwater JY, Koutrouvelis PG.

Cancer. 2000 Nov 15;89(10):2085-91.

PMID:
11066049
8.

Tribute to William W. Scott.

Gillenwater JY.

J Urol. 2000 Sep;164(3 Pt 1):633. No abstract available.

PMID:
10953113
9.

High- and low-risk prostate cancer treated with 3D CT-guided brachytherapy: 1-to 5-year follow-up.

Koutrouvelis P, Lailas N, Katz S, Goldson A, Gilmontero G, Bondy H, Hendricks F, Sehn JT, Schwartz D, Khawand N, Willis A, Gillenwater JY.

J Endourol. 2000 May;14(4):357-66.

PMID:
10910152
10.

Osteocalcin-directed gene therapy for prostate-cancer bone metastasis.

Koeneman KS, Kao C, Ko SC, Yang L, Wada Y, Kallmes DF, Gillenwater JY, Zhau HE, Chung LW, Gardner TA.

World J Urol. 2000 Apr;18(2):102-10.

PMID:
10854144
11.

Determination of optimal freezing parameters of human prostate cancer in a nude mouse model.

Turk TM, Rees MA, Pietrow P, Myers CE, Mills SE, Gillenwater JY.

Prostate. 1999 Feb 1;38(2):137-43.

PMID:
9973099
12.
13.

Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation.

Crane CH, Rich TA, Read PW, Sanfilippo NJ, Gillenwater JY, Kelly MD.

Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):681-6.

PMID:
9336150
14.

Radical prostatectomy with preservation of urinary continence.

Gaker DL, Gaker LB, Stewart JF, Gillenwater JY.

J Urol. 1996 Aug;156(2 Pt 1):445-9.

PMID:
8683699
15.

Tentative direct antimicrobial susceptibility testing in urine.

Gillenwater JY, Clark MM.

J Urol. 1996 Jul;156(1):149-53.

PMID:
8648778
17.
18.

Bladder outlet obstruction after multiple periurethral polytetrafluoroethylene injections.

McKinney CD, Gaffey MJ, Gillenwater JY.

J Urol. 1995 Jan;153(1):149-51.

PMID:
7966753
19.

John Thomas Grayhack: the ideal role model.

Gillenwater JY.

J Urol. 1994 Dec;152(6 Pt 2):2215-8. No abstract available.

PMID:
7966712
20.

National institute of kidney and urologic diseases.

Gillenwater JY.

J Urol. 1994 Aug;152(2 Pt 1):491. No abstract available.

PMID:
8015099
21.

Has the American Urological Association made a difference?

Gillenwater JY.

J Urol. 1992 Sep;148(3):772-4. No abstract available.

PMID:
1512823
22.

Digital rectal examination-associated alterations in serum prostate-specific antigen.

Gillenwater JY.

Am J Clin Pathol. 1992 Apr;97(4):466-7. No abstract available.

PMID:
1372786
23.

Urology.

Leadbetter GW Jr, Gillenwater JY.

JAMA. 1991 Jun 19;265(23):3175-6. No abstract available.

PMID:
2041143
24.

The role of the urologist in urinary tract infection.

Gillenwater JY.

Med Clin North Am. 1991 Mar;75(2):471-9. Review.

PMID:
1996044
25.

The effect of ursodiol on the efficacy and safety of extracorporeal shock-wave lithotripsy of gallstones. The Dornier National Biliary Lithotripsy Study.

Schoenfield LJ, Berci G, Carnovale RL, Casarella W, Caslowitz P, Chumley D, Davis RC, Gillenwater JY, Johnson AC, Jones RS, et al.

N Engl J Med. 1990 Nov 1;323(18):1239-45.

26.

Renal liposarcoma.

Mayes DC, Fechner RE, Gillenwater JY.

Am J Surg Pathol. 1990 Mar;14(3):268-73. Review.

PMID:
2407142
27.

Inferior vena caval invasion by renal cell carcinoma: false positive diagnosis by venacavography.

Selby JB Jr, Pryor JL, Tegtmeyer CJ, Gillenwater JY.

J Urol. 1990 Mar;143(3):464-7.

PMID:
2304154
28.
29.

Extracorporeal shock wave lithotripsy and infection.

Gillenwater JY.

J Urol. 1988 Aug;140(2):353. No abstract available.

PMID:
3398135
31.
32.

The role of radiology in extracorporeal shock wave therapy.

Kellum CD, Tegtmeyer CJ, Jenkins AD, Barr JD, Gillenwater JY, Wyker AW, Lippert MC.

Radiology. 1987 Nov;165(2):431-8.

PMID:
3310097
33.

Extracorporeal shock wave lithotripsy: interventional radiologic solutions to associated problems.

Tegtmeyer CJ, Kellum CD, Jenkins A, Gillenwater JY, Way WG, Barr J, Piros G, Springer R, Lippert MC, Wyker AW.

Radiology. 1986 Dec;161(3):587-92.

PMID:
3786704
34.

A new surgical technique for phalloplasty in patients with exstrophy of the bladder.

Edgerton MT, Gillenwater JY.

Plast Reconstr Surg. 1986 Sep;78(3):399-410.

PMID:
3526371
35.

Complications following ureteroscopy.

Biester R, Gillenwater JY.

J Urol. 1986 Aug;136(2):380-2.

PMID:
3735499
36.

Shock-wave lithotripsy for the removal of kidney stones.

Gillenwater JY, Jenkins AD.

Va Med. 1985 Mar;112(3):182-3. No abstract available.

PMID:
3984474
37.

The bladder flap for urethral reconstruction in total phalloplasty.

Edgerton MT, Gillenwater JY, Kenney JG, Horowitz J.

Plast Reconstr Surg. 1984 Aug;74(2):259-66.

PMID:
6540460
38.

Catheter-associated bacteriuria. Failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systems.

Thompson RL, Haley CE, Searcy MA, Guenthner SM, Kaiser DL, Gröschel DH, Gillenwater JY, Wenzel RP.

JAMA. 1984 Feb 10;251(6):747-51.

PMID:
6363727
39.

Immunoblastic sarcoma of the bladder.

Forrest JB, Saypol DC, Mills SE, Gillenwater JY.

J Urol. 1983 Aug;130(2):350-1.

PMID:
6192255
40.

Use of beta-lactam antibiotics in urinary tract infections.

Gillenwater JY.

J Urol. 1983 Mar;129(3):457-60. No abstract available.

PMID:
6550636
41.

The hand vacuum cleaner: friend or foe?

Forrest JB, Gillenwater JY.

J Urol. 1982 Oct;128(4):829. No abstract available.

PMID:
7143616
42.

An autosomal dominant syndrome of radial hypoplasia, triphalangeal thumbs, hypospadias, and maxillary diastema.

Schmitt E, Gillenwater JY, Kelly TE.

Am J Med Genet. 1982 Sep;13(1):63-9.

PMID:
7137222
43.

Mechanical factors and tissue stresses in chronic hydronephrosis.

Wyker AT, Ritter RC, Marion Dn, Gillenwater JY.

Invest Urol. 1981 May;18(8):430-6.

PMID:
7228575
44.

Detection of urinary leukocytes by chemstrip-l.

Gillenwater JY.

J Urol. 1981 Mar;125(3):383-4.

PMID:
7206089
45.

Osmotic effects of intravenous contrast agents on renal function.

Forrest JB, Howards SS, Gillenwater JY.

J Urol. 1981 Feb;125(2):147-50.

PMID:
7206041
46.

Evaluation of Uricult dip slide in two hospital populations.

Winn WC Jr, Gillenwater JY.

Urology. 1980 Jan;15(1):44-6.

PMID:
6986068
47.
48.

Natural history of bacteriuria in schoolgirls. A long-term case-control study.

Gillenwater JY, Harrison RB, Kunin CM.

N Engl J Med. 1979 Aug 23;301(8):396-9.

PMID:
460340
49.

Patterns of recovery of renal function after surgical relief of chronic bilateral partial ureteral obstruction.

Miller JB, Marion DN, Gillenwater JY.

Invest Urol. 1979 Jul;17(1):69-74.

PMID:
447489
50.

Familial pheochromocytoma, hypercalcemia, and von Hippel-Lindau disease. A ten year study of a large family.

Atuk NO, McDonald T, Wood T, Carpenter JT, Walzak MP, Donaldson M, Gillenwater JY.

Medicine (Baltimore). 1979 May;58(3):209-18.

PMID:
449657

Supplemental Content

Loading ...
Support Center